{"version":"1.0","provider_name":"Basel Area Business &amp; Innovation","provider_url":"https:\/\/test.baselarea.swiss\/de\/","author_name":"J\u00e9r\u00e9mie Meyer","author_url":"https:\/\/test.baselarea.swiss\/de\/author\/jeremie\/","title":"Alentis nimmt 12,5 Millionen Franken ein","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"c94HBq8tOm\"><a href=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/alentis-nimmt-125-millionen-franken-ein\/\">Alentis nimmt 12,5 Millionen Franken ein<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/alentis-nimmt-125-millionen-franken-ein\/embed\/#?secret=c94HBq8tOm\" width=\"600\" height=\"338\" title=\"&#171;Alentis nimmt 12,5 Millionen Franken ein&#187; &#8212; Basel Area Business &amp; Innovation\" data-secret=\"c94HBq8tOm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/test.baselarea.swiss\/\/wp-content\/uploads\/2019\/04\/Thomas-Baumert-Alentis.jpg","thumbnail_width":900,"thumbnail_height":450,"description":"Das Basler Biotechunternehmen Alentis Therapeutics AG hat bei einer Serie-A-Finanzierungsrunde 12,5 Millionen Franken eingenommen. Die Finanzierung f\u00fchrten die Schweizer Risikokapitalfirmen BioMedPartners und BB Pureos Bioventures an, welchem sich BPI France, Schroder Adveq und der HTGF anschlossen. Alentis entwickelt Medikamente zur Behandlung fortgeschrittener Lebererkrankungen und Krebs."}